JF
MDGL icon

Jump Financial’s Madrigal Pharmaceuticals MDGL Stock Holding History

Jump Financial’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.03M Buy
11,225
+10,030
+839% +$5.14M 0.05% 439
2026
Q1 		$626K Sell
1,195
-18,026
-94% -$8.61M 0.01% 1135
2025
Q4 		$11.2M Sell
19,221
-1,735
-8% -$886K 0.14% 179
2025
Q3 		$9.61M Buy
+20,956
New +$7.82M 0.11% 226
2025
Q1 		– Sell
-682
Closed -$210K – 1849
2024
Q4 		$210K Buy
+682
New +$192K ﹤0.01% 1466
2023
Q4 		– Sell
-2,359
Closed -$345K – 2048
2023
Q3 		$345K Buy
2,359
+868
+58% +$163K 0.01% 1228
2023
Q2 		$344K Sell
1,491
-19,304
-93% -$5.23M 0.01% 1239
2023
Q1 		$5.04M Buy
20,795
+16,207
+353% +$4.42M 0.21% 149
2022
Q4 		$1.33M Buy
+4,588
New +$449K 0.07% 378

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jump Financial's MDGL Position: Q2 2026 in Review

Jump Financial increased its Madrigal Pharmaceuticals (MDGL) stake by 839% in Q2 2026, buying an estimated $5.14M and bringing the position to 11,225 shares worth $6.03M. The position accounts for 0.05% of the portfolio, ranked #439.

Jump Financial first reported a position in MDGL in Q4 2022 and has held it in 9 quarters since. The position peaked at $11.2M in Q4 2025. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Jump Financial held 11,225 shares of Madrigal Pharmaceuticals worth $6.03M as of Q2 2026.
  • Jump Financial bought 10,030 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $5.14M.
  • Madrigal Pharmaceuticals made up 0.05% of Jump Financial's portfolio in Q2 2026, its #439 holding.
  • Jump Financial first reported a position in Madrigal Pharmaceuticals in Q4 2022 and has held it in 9 quarters since.
  • Jump Financial's Madrigal Pharmaceuticals position peaked at $11.2M in Q4 2025.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.